These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 16550531
21. Expanding the role of hydroxyurea in children with sickle cell disease. Rogers ZR, Buchanan GR. J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174 [No Abstract] [Full Text] [Related]
22. Hydroxurea and sickle cell disease: Its been a long, long time coming. Scott JP. Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298 [No Abstract] [Full Text] [Related]
23. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE. Blood; 1999 Sep 01; 94(5):1550-4. PubMed ID: 10477679 [Abstract] [Full Text] [Related]
24. Sickle cell disease--pathophysiology and treatment. Redding-Lallinger R, Knoll C. Curr Probl Pediatr Adolesc Health Care; 2006 Sep 01; 36(10):346-76. PubMed ID: 17055417 [No Abstract] [Full Text] [Related]
25. Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa. John CC, Opoka RO, Latham TS, Hume HA, Nabaggala C, Kasirye P, Ndugwa CM, Lane A, Ware RE. N Engl J Med; 2020 Jun 25; 382(26):2524-2533. PubMed ID: 32579813 [Abstract] [Full Text] [Related]
26. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not. Nwenyi E, Leafman J, Mathieson K, Ezeobah N. Int J Health Care Qual Assur; 2014 Jun 25; 27(6):468-81. PubMed ID: 25115050 [Abstract] [Full Text] [Related]
28. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia. Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA. Haematologica; 2004 Mar 25; 89(3):273-80. PubMed ID: 15020264 [Abstract] [Full Text] [Related]
29. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, Smith-Whitley K, Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR. J Pediatr; 2002 Feb 25; 140(2):225-9. PubMed ID: 11865275 [Abstract] [Full Text] [Related]
30. Hydroxyurea therapy: improving the lives of patients with sickle cell disease. Anderson N. Pediatr Nurs; 2006 Feb 25; 32(6):541-3. PubMed ID: 17256291 [Abstract] [Full Text] [Related]
38. From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia. Hankins JS, Aygun B, Nottage K, Thornburg C, Smeltzer MP, Ware RE, Wang WC. Medicine (Baltimore); 2014 Dec 25; 93(28):e215. PubMed ID: 25526439 [Abstract] [Full Text] [Related]
39. Massive accidental overdose of hydroxyurea in a young child with sickle cell anemia. Miller ST, Rey K, He J, Flanagan J, Fish BJ, Rogers ZR, Wang WC, Ware RE, BABY HUG Investigators. Pediatr Blood Cancer; 2012 Jul 15; 59(1):170-2. PubMed ID: 21744485 [Abstract] [Full Text] [Related]